drugset / Trial / NCT02025751

Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis

NCT02025751

Phase 3 Completed 53 enrolled Evoke Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is evaluate the safety and efficacy of Metoclopramide Nasal Spray compared to placebo in reducing the symptoms of diabetic gastroparesis in adult men.

Timeline

Start
2014-04
Primary completion
2016-08
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Metoclopramide Small molecule 10 mg Intranasal

Indications